πŸ›οΈ Verified NIH Record β€’ Updated 2026-05-27

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes (NCT07282613)

Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. Once Weekly Versus Placebo in Children and Adolescents With Type 2 Diabetes

🟑 Not Yet Recruiting Phase3 πŸ’Š Investigational Drug / Biologic Sponsor: Novo Nordisk A/S

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this clinical study is to look into how well a study medicine called CagriSema helps children and adolescents living with diabetes lower their blood sugar and body weight. The study has 2 parts: in the first part participant will get either CagriSema or placebo, and in the second part participant will get CagriSema. In the first part, which treatment participant gets is decided by chance and second part is open label and all participants will get CagriSema during this part. The study will last for about 1 year and 3 months.

Who can join: Review the eligibility criteria below.

Location: Yale School of Medicine β€” New Haven, Connecticut

Age range: 10 Years to 18 Years

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (56 Sites)

Showing the first 25 of 56 sites.

  • Yale School of Medicine β€” New Haven, Connecticut
  • Encore Medical Research Boynton Beach β€” Boynton Beach, Florida
  • Nemours Chld Clnc Jacksonville β€” Jacksonville, Florida
  • Innovus Clinical β€” Kissimmee, Florida
  • D&H National Research Centers β€” Tamarac, Florida
  • Clinical Research Trials of Florida β€” Tampa, Florida
  • Columbus Research Foundation β€” Columbus, Georgia
  • Eastside Bariatric and Gen Surg β€” Snellville, Georgia
  • SIU Medicine β€” Springfield, Illinois
  • Riley Hospital For Children β€” Indianapolis, Indiana
  • University of Iowa β€” Iowa City, Iowa
  • Great Lakes Research Inst. β€” Southfield, Michigan
  • UBMD Pediatrics β€” Buffalo, New York
  • NYU Langone Orthopedic Center β€” New York, New York
  • Children's Hosptl Philadelphia β€” Philadelphia, Pennsylvania
  • Monument Health Clinical Rsrch β€” Rapid City, South Dakota
  • LifeDoc Health β€” Memphis, Tennessee
  • Amir Ali Hassan, MD, PA β€” Houston, Texas
  • Consano Clinical Research, LLC β€” Shavano Park, Texas
  • UVA Health Systems β€” Charlottesville, Virginia
  • Seattle Children's Research Institute β€” Seattle, Washington
  • Centro de Investigaciones MetabΓ³licas β€” Capital Federal, Buenos Aires
  • Centro de InvestigaciΓ³n C.I.C.E 9 de Julio - Sanatorio 9 de Julio β€” San Miguel de TucumΓ‘n, TucumΓ‘n Province
  • IMOBA β€” City of Buenos Aires,
  • ClΓ­nica Mayo de Urgencias MΓ©dicas Cruz Blanca β€” San Miguel de TucumΓ‘n,

πŸ“ž Contact the Study Coordinator

Phone: (866) 867-7178

Email: clinicaltrials@novonordisk.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—